Bottom line
Is ASCGX a good fund? The bottom line
ASCGX is a managed small-cap mutual fund from Forum.
Annual fees run 3.06% — about $306 a year on every $10,000 invested, more expensive than 100% of small-cap funds we track.
It returned +9.8% over one year, +0.3% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $18.7 million in net assets and 89 holdings, its largest position is BrightSpring Health Services I (2.9%) and the top 10 make up 21% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (3.06%)
- 5-year return in the bottom quarter of its category
- Small fund ($18.7 million) — small funds are likelier to close
- High turnover (358% a year) can mean more taxable distributions
Updated Nov 19, 2026
What ASCGX invests in
The Lisanti Small Cap Growth Fund (the Fund) seeks maximum capital appreciation.
Under normal market conditions, the Fund invests at least 80% of its net assets (plus borrowings for investment purposes) in the equity securities of smaller, lesser-known companies whose stocks are traded in the U.S. markets. Smaller companies are generally defined by the Adviser as those with market capitalizations in the range of $12.3 million to $37.4 billion, which was the three-year average minimum and maximum market capitalizations of companies in the Russell 2000 Growth Index as of March 31, 2026. The Fund normally invests in companies that the Adviser believes are in an early stage or transitional point in their development and have above average prospects for growth. Investments may include initial public offerings (IPOs) of such companies. The Funds investment process focuses on 1) security selection through a quantitative screening process of the universe of smaller…
From the fund's prospectus (filed Apr 22, 2026).
ASCGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| ASCGX | +9.8% | +0.3% | +10.1% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What ASCGX costs
On a $10,000 investment, ASCGX's 3.06% expense ratio costs about $306 a year. The prospectus estimates $3,374 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
ASCGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | BrightSpring Health Services I | 2.95% |
| 2 | Hinge Health Inc | 2.49% |
| 3 | Ultra Clean Holdings Inc | 2.32% |
| 4 | Xometry Inc | 2.11% |
| 5 | Silicon Motion Technology Corp | 2.04% |
| 6 | Solaris Energy Infrastructure | 2.01% |
| 7 | Extreme Networks Inc | 1.83% |
| 8 | RBC Bearings Inc | 1.78% |
| 9 | DigitalOcean Holdings Inc | 1.74% |
| 10 | Corcept Therapeutics Inc | 1.71% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 21% of the fund. See all top 25 holdings and asset mix →